Consensus Statement On Hormone Therapy

NORTH AMERICA MENOPAUSE SOCIETY

A statement has been jointly prepared by the North Amer­i­can Menopause Society, the Endocrine Society, and the America Society of Repro­duc­tive Med­i­cine, and endorsed by 12 other medical societies in the United States, Canada, and Mexico.

This con­sen­sus statement affirms that hormone therapy (HRT) con­tin­ues to have an important clin­i­cal role in the man­age­ment of women with menopausal symptoms. The purpose of this statement is to reassure women and their healthcare providers that hormone therapy is acceptable and rel­a­tively safe for healthy, symp­to­matic, recently post­menopausal women.

The con­sen­sus statement concluded that hormone therapy con­tin­ues to be an acceptable option for women with moderate-to-severe hot flashes, night sweats, and other menopausal symptoms, and it is best started in any menopause woman (within 10 years of the onset of menopause) or by age 50. Indi­vid­u­al­iza­tion is key, and a women’s clin­i­cal factors should be taken into account, including age, time since menopause, and medical history.

The type of hormone therapy is what makes the dif­fer­ence. Bio Iden­ti­cal hormones, which are mol­e­c­u­larly iden­ti­cal in structure to hormones found in the human body, are the preferred method. When hormone therapy is needed, we rec­om­mend the use of bio iden­ti­cal hormones such as estra­diol, estriol, prog­es­terone, testosterone or DHEA, and natural thyroid hormones.

Hormones are crit­i­cal for all types of bodily functions. We know that when hormone levels decline as part of the normal aging process, problems with health arise. Bio Iden­ti­cal hormones can relieve symptoms, improve quality of life, prevent chronic illness and maintain wellness. We work with each woman to customize hormone therapy based on her indi­vid­ual lab results. We mon­i­tor each woman’s symptoms as well as follow up lab tests to rec­om­mend changes when needed.

North America Menopause Society
Endocrine Society